Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease

Kidney International

Volumn 72, Issue 2, 2007, Pages 137-140

  Mehrotra, R ^a,b,c  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN; INSULIN;

BONE DEVELOPMENT; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; HEMODIALYSIS PATIENT; HUMAN; INSULIN RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW;

EID: 34447523396     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002355     Document Type: Note

References (12)

1. Kalpakian MA, Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial 2007; 20: 139-143.
2. Hermans MMH, Brandenburg V, Ketteler M et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72: 202-207.
3. Szweras M, Liu D, Partridge EA et al. α2-HS glycoprotein/fetuin, a transforming growth factor β/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002; 277: 19991-19997.
4. Kundranda MN, Ray S, Saria M et al. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochim Biophys Acta 2004; 1693: 111-123.
5. Chen NX, O'Neill KD, Chen Z et al. Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am J Physiol Renal Physiol 2007; 292: F599-F606.
6. Reynolds JL, Skepper JN, McNair R et al. Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005; 16: 2920-2930.
7. Stenvinkel P, Wang K, Qureshi AR et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in genes encoding fetuin. Kidney Int 2005; 67: 2383-2392.
8. Wang AYM, Woo J, Lam CWK et al. Associations of serum fetuin-A with malnutrition, atherosclerosis, and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685.
9. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833.
10. Mehrotra R, Westenfeld R, Christenson P et al. Serum fetuin-A in non-dialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 2005; 67: 1070-1077.
11. Stefan N, Hennige AM, Staiger H et al. α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853-857.
12. Jersmann HP, Dransfiled I, Hart SP. Fetuin/α2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci 2003; 105: 273-278.